Understanding and treating abnormal bone growth after injury or genetic disorders
Mechanistic and Therapeutic Studies of Initiation and Expansion for Genetic and Acquired Heterotopic Ossification
This study is looking into how and why extra bone forms in places it shouldn't, often after injuries or due to genetic issues, and aims to find new ways to prevent or treat this condition, which could help patients in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University Health Science Ctr NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-11177226 on NIH RePORTER |
What this research studies
This research investigates the cellular and molecular mechanisms behind heterotopic ossification (HO), which is the abnormal formation of bone in areas where bone should not exist, often occurring after injuries or due to genetic conditions. The study aims to identify potential treatment targets by examining how certain cells contribute to this process and how they can be manipulated to prevent or reduce HO. By using mouse models and human samples, the researchers will explore the roles of specific genes and signaling pathways involved in bone formation. Patients may benefit from new therapeutic strategies that could emerge from this understanding.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced injuries leading to heterotopic ossification or those with genetic disorders associated with abnormal bone growth.
Not a fit: Patients with conditions unrelated to bone formation or those who do not have a history of injuries leading to heterotopic ossification may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective treatments for patients suffering from heterotopic ossification, improving their quality of life.
How similar studies have performed: Previous research has shown promise in understanding the mechanisms of heterotopic ossification, but this specific approach is novel and aims to uncover new therapeutic targets.
Where this research is happening
College Station, United States
- Texas A&m University Health Science Ctr — College Station, United States (Active)
Researchers
- Principal investigator: Cong, Qian — Texas A&m University Health Science Ctr
- Study coordinator: Cong, Qian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.